Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

PHASE2UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2016

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

Dasatinib

Trial Locations (15)

15706

Complejo Hospitalario Universitario de Santiago, Santiago de Compostela

24071

Hospital de León, León

26006

Hospital San Pedro de La Rioja, Logroño

28006

Hospital Universitario de la Princesa, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28041

Hospital 12 de Octubre, Madrid

28046

Hospital Universitario La Paz, Madrid

33006

Hospital Universitario Central de Asturias, Oviedo

36211

Hospital POVISA, Vigo

37007

Hospital Universitario de Salamanca, Salamanca

41013

Hospital Virgen del Rocío, Seville

45004

Complejo Hospitalario de Toledo - Hospital Virgen de la Salud, Toledo

01010

Hospital Txagorritxu, Vitoria-Gasteiz

Unknown

Hospital Germans Trias i Pujol, Badalona

08907

Institut Catalá d'Oncologia L'Hospitallet, Barcelona

Sponsors
All Listed Sponsors
collaborator

Dynamic Solutions

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

PETHEMA Foundation

OTHER